Full Text View
Tabular View
No Study Results Posted
Related Studies
Sevoflurane and Laryngeal Reflex Responses in Pediatric Patients
This study has been terminated.
( Recruitment finished earlier, because all 40 patients enrolled )
Study NCT00665418   Information provided by University Hospital, Basel, Switzerland
First Received: January 23, 2008   Last Updated: March 11, 2009   History of Changes

January 23, 2008
March 11, 2009
February 2008
August 2008   (final data collection date for primary outcome measure)
Occurence of laryngospasm (defined as complete closure of the vocal or false cords with apnea lasting >10sec) after laryngeal stimulation [ Time Frame: 5min ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00665418 on ClinicalTrials.gov Archive Site
 
 
 
Sevoflurane and Laryngeal Reflex Responses in Pediatric Patients
Impact of High Concentrations of Sevoflurane on Laryngeal Reflex Responses in Pediatric Patients

To describe laryngeal and respiratory reflex responses after controlled laryngeal stimulation in pediatric patients anesthetized with sevoflurane and to compare the evoked responses at two levels of anesthesia. To determine whether laryngeal and respiratory reflex responses after controlled laryngeal stimulation are completely suppressed in subjects when anesthetized with a MACEI95 (EI = endotracheal intubation) sevoflurane Hypothesis: The incidence of apnea with laryngospasm evoked by laryngeal stimulation will be reduced by 20% (from 25% to 5%) when the end-tidal concentration of sevoflurane is increased from 2.5% (MAC50) to 4.7% (MACEI95)

Induction of anesthesia inhaling sevoflurane is a very common practice in pediatric anesthesia.However, unwarranted exaggerated upper airway defensive reflexes that develop into apnea and laryngospasm with resultant hypoxemia is more common and also more severe.

Despite their obvious clinical significance, reflexes that involve the function of the upper airway are only minimally understood and information on such reflexes is scarce in anesthetized humans. Nonetheless, a model was developed by analyzing respiratory variables and endoscopic images after stimulating the laryngeal mucosa with a small amount of distilled water. Clinical experience suggests that laryngeal reflexes occur more frequently under light levels of anesthesia. However, in contrast to other inhalational agents such as halothan, available data for sevoflurane suggest that an inverse correlation of laryngeal responsiveness to depth of hypnosis or end-tidal concentrations of sevoflurane (in adults and children) is less obvious. However, in all previous studies assessing laryngeal reflex responses under sevoflurane only low concentrations of sevoflurane (range of 1.0 - 2.5 Vol%) were examined. This is an important limitation because in clinical practice higher concentrations of sevoflurane are used, especially during manipulation of the airway, while the risk of airway irritation is high. Thus, the proposed study aims to explore the question whether the occurrence of laryngospasm can be reliably suppressed when high concentrations of sevoflurane are used.

Based on results of experiments assessing conditions that facilitate tracheal intubation, it is clear, that increasing the end-tidal concentration of volatile agents obtunds airway reflexes. Regarding intubation conditions, the concept of MACEI 50% or 95% describes the minimum alveolar concentration (MAC) of a volatile anesthetic needed by 50 or 95% of the patients, respectively, to prevent all movement during and immediately after tracheal intubation. The proposed study aims to assess respiratory reflex responses at these levels of anesthesia by analyzing the respiratory variables and endoscopic images. The incidences of well-defined airway reflexes (cough reflex, spasmodic panting, expiration reflex, and apnea with laryngospasm, central apnea) will be examined. Apnea with laryngospasm will be of primary interest in our study and digital video analysis of the glottic opening will allow for a detailed analysis of laryngeal performance.

Phase IV
Interventional
Prevention, Open Label, Dose Comparison, Single Group Assignment, Efficacy Study
Laryngospasm
Drug: sevoflurane
 
Oberer C, von Ungern-Sternberg BS, Frei FJ, Erb TO. Respiratory reflex responses of the larynx differ between sevoflurane and propofol in pediatric patients. Anesthesiology. 2005 Dec;103(6):1142-8.

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Terminated
40
August 2008
August 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • ASA I + II
  • Elective intervention under general anesthesia

Exclusion Criteria:

  • Reactive airway disease
  • Respiratory tract infection (previous 2 weeks)
  • Malignant hyperthermia
  • Neuromuscular disease
  • Cardiac disease
Both
25 Months to 84 Months
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00665418
Albert Urwyler MD, Department of Anesthesia
UNIBAS_UKBB_ANE_LR4, SNF_3200B0-109322
University Hospital, Basel, Switzerland
 
Principal Investigator: Thomas O Erb, MD Universitiy children's hospital Basel
University Hospital, Basel, Switzerland
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP